results when the initial urinary steroid excretion (17-KGS, 17-OHCS) is low. The response may be negative in patients with myxoedema, liver disease or pregnancy or when certain drugs are given such as cestrogens, anabolic steroids or chlorpromazine. Further, because of the marked diurnal sensitivity to metyrapone administration it is most important that a suitable dose be given at midnight and at 4 a.m. or a false negative result may be obtained.
Insulin hypoglycwemia is of great value in testing the hypothalamic-pituitary-adrenal axis but it must be carried out with due attention to its limitations. It is important that the fasting plasma glucose is reduced to at least 40% of its initial value within twenty to thirty minutes of the administration of the insulin. Hypoglycaemia of less intensity may fail to elicit a response. Patients with obesity and Cushing's disease may be unresponsive as are patients who have previously received glucocorticoids. The test must be carried out under skilled medical supervision and otherwise is unsuitable as a screening procedure.
Lysine-8-vasopressin administration is a useful test of pituitary function and is best carried out by intramuscular administration of 10 units of the synthetic peptide. The test should be performed in the afternoon rather than in the morning because of the greater sensitivity at this time. False negative responses are found sometimes without apparent explanation but often when patients have been given glucocorticoids before. The test is not without risk and should not be carried out on patients suspected of coronary insufficiency. The response of the 'normal' child to adrenocorticotrophic hormone and the measurement of his cortisol production rate have been reasonably well standardized. These tests can be used to investigate pathological conditions. The use of the metyrapone test in children has been evaluated, and it has been concluded that it is unsatisfactory. The use of pyrogen and lysine vasopressin to stimulate the pituitary-adrenal axis will be discussed. The results of a study comparing the effects of long-term corticosteroids, a combination of corticosteroids and ACTH, and ACTH alone on the growth velocity of children is described. Growth velocity is decreased by corticosteroids leading to stunting of growth whereas ACTH, in sufficient doses to control the signs and symptoms of the disease being treated, increases the growth velocity.
The plasma cortisol response to insulininduced hypoglycLemia has been investigated in a group of normal adults, patients on long-term steroids and children on long-term ACTH: (a) Only 3 of 24 patients on long-term corticosteroids had a normal plasma cortisol response to intravenous insulin; the response obtained is dose dependent. (b) Twelve of 13 children on longterm ACTH gave a normal response in plasma cortisol following intravenous insulin; previous steroid therapy affected the maximum level of plasma cortisol attained after insulin. From this study we conclude that ACTH does not suppress the pituitary-adrenal axis to the same extent as long-term corticosteroids. Anabolic adrenal steroids which are suppressed on corticosteroid therapy may be secreted on ACTH therapy.
The plasma growth hormone response to insulin-induced hypoglycemia has been studied in The difference in growth hormone response to insulin-induced hypoglycemia may be a factor in accounting for the difference in growth velocity observed between the groups treated with ACTH and with corticosteroids. A radioimmunological method was used to detect antibodies to porcine ACTH in children on long-term therapy with porcine ACTH. Thirteen of 19 children had detectable antibodies to porcine
